How Much Can Pharma Lose?
When attempting to regulate pharmaceutical spending, policymakers frequently assert that pharmaceutical manufacturer returns are significantly higher than other industries. A 2006 Congressional Budget Office report was among the first to systematically assess the question and provide support to some lawmakers’ belief that the pharmaceutical industry could remain pro table with lower revenues.
